Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A OTT

Showing results (171-180 of 769) with videos related to

Pageof 77
Sort By:
Cancer Discovery|January 25, 2020
Directing Traffic: How to Effectively Drive T Cells into TumorsAnnabelle J Anandappa, Catherine J Wu, Patrick A Ott
Clinical Immunology (Orlando, Fla.)|July 17, 2007
The secretory IFN-gamma response of single CD4 memory cells after activation on different antigen presenting cell typesPatrick A Ott, Magdalena Tary-Lehmann, Paul V Lehmann
JMIR Formative Research|December 13, 2023
Assessing Facilitator Fidelity to Principles of Public Deliberation: TutorialClaire Draucker, Andrés Carrión, Mary A Ott, et al.
Drugs|November 22, 2014
The biology and clinical development of MEK inhibitors for cancerJason J Luke, Patrick A Ott, Geoffrey I Shapiro
The Journal of Pediatrics|March 12, 2018
Factors Influencing Pediatric Resident Exposure to Adolescents in their Continuity ClinicLaura S Price, Lisa A Cao, Mary A Ott
Journal of Biochemical and Biophysical Methods|May 27, 1999
Microplates: a new tool for manipulation and mechanical perturbation of individual cellsO Thoumine, A Ott, O Cardoso, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 1, 1983
Surgical treatment of aneurysm of the ascending aorta with aortic insufficiency. A selective approachD P Grey, D A Ott, D A Cooley
Instructional Course Lectures|January 1, 1993
Electrical stimulation of soft tissuesE M Wojtys, J E Carpenter, G A Ott
Journal of the American Chemical Society|June 3, 2017
Dynamic Kinetic Resolution of Allylic Azides via Asymmetric DihydroxylationAmy A Ott, Charles S Goshey, Joseph J Topczewski
Investigational New Drugs|April 25, 2023
A phase I/II study of MCS110 with BRAF/MEK inhibition in patients with melanoma after progression on BRAF/MEK inhibitionElizabeth I Buchbinder, Anita Giobbie-Hurder, Patrick A Ott
Pageof 77

Showing results (171-180 of 769) with videos related to

Sort By:
Pageof 77
Cancer Discovery|January 25, 2020
Directing Traffic: How to Effectively Drive T Cells into TumorsAnnabelle J Anandappa, Catherine J Wu, Patrick A Ott
Clinical Immunology (Orlando, Fla.)|July 17, 2007
The secretory IFN-gamma response of single CD4 memory cells after activation on different antigen presenting cell typesPatrick A Ott, Magdalena Tary-Lehmann, Paul V Lehmann
JMIR Formative Research|December 13, 2023
Assessing Facilitator Fidelity to Principles of Public Deliberation: TutorialClaire Draucker, Andrés Carrión, Mary A Ott, et al.
Drugs|November 22, 2014
The biology and clinical development of MEK inhibitors for cancerJason J Luke, Patrick A Ott, Geoffrey I Shapiro
The Journal of Pediatrics|March 12, 2018
Factors Influencing Pediatric Resident Exposure to Adolescents in their Continuity ClinicLaura S Price, Lisa A Cao, Mary A Ott
Journal of Biochemical and Biophysical Methods|May 27, 1999
Microplates: a new tool for manipulation and mechanical perturbation of individual cellsO Thoumine, A Ott, O Cardoso, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 1, 1983
Surgical treatment of aneurysm of the ascending aorta with aortic insufficiency. A selective approachD P Grey, D A Ott, D A Cooley
Instructional Course Lectures|January 1, 1993
Electrical stimulation of soft tissuesE M Wojtys, J E Carpenter, G A Ott
Journal of the American Chemical Society|June 3, 2017
Dynamic Kinetic Resolution of Allylic Azides via Asymmetric DihydroxylationAmy A Ott, Charles S Goshey, Joseph J Topczewski
Investigational New Drugs|April 25, 2023
A phase I/II study of MCS110 with BRAF/MEK inhibition in patients with melanoma after progression on BRAF/MEK inhibitionElizabeth I Buchbinder, Anita Giobbie-Hurder, Patrick A Ott
Pageof 77